CLINICAL_TRIALS
trial_result
· 2021-09-02
Clinical Trial Update: Anxiolytic and Analgesic Effects of Melatonin [Phase 3]
Summary
Phase 3 clinical trial investigating melatonin for anxiolytic and analgesic effects has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Herlev Hospital | Conditions: Anxiety | Phase 3 | Status: COMPLETED | Results posted: 2021-09-02